Two-year clinical outcomes of the "Italian diffuse/multivessel disease absorb prospective registry" (IT-DISAPPEARS)

Nei pazienti con lesioni coronariche complesse, i BVS possono fornire esiti clinici accettabili? (Int J Cardiol 9 May 3. pii: S0167-5273(18)36448-9)

30 Maggio Mag 2019 6 months ago
  • Bartorelli AL

Large prospective studies on the use of bioresorbable vascular scaffolds (BVS) for diffuse coronary artery disease are lacking. IT DISAPPEARS is a large multicentre prospective registry investigating the short and long-term outcomes of everolimus-eluting BVS in patients with long coronary lesions and/or multivessel coronary artery disease. In this paper, the Authors report the 2-year outcomes of the registry.

The report show that BVS may yield acceptable clinical outcomes in patients with complex coronary lesions when the implantation technique is appropriate.


Reference
1. De Carlo M, Testa L, Leoncini M, Nicolini E, Varbella F, Cortese B, Ribichini F, Bartorelli AL, Calabria P, Indolfi C, Tomai F, Loi B, Fischietti D, Tarantini G, Bedogni F, Petronio AS. Two-year clinical outcomes of the "Italian diffuse/multivessel disease absorb prospective registry" (IT-DISAPPEARS). Int J Cardiol 9 May 3. pii: S0167-5273(18)36448-9. doi: 10.1016/j.ijcard.2019.04.095 Go to PubMed